Lo Andrew

CIK 00016790767 companiesVANCOUVER, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001679076

Recent Transactions

50 trades

Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-11-18$65.23/sh−24,007→ 81,576 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-11-18$66.05/sh−30,993→ 50,583 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-11-17$67.06/sh−3,798→ 14,089 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-11-17$66.63/sh−36,801→ 17,887 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2025-06-20+8,425→ 8,425 total
Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-06-20+6,589→ 54,688 total
Award
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2025-06-12+238,864→ 541,354 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-05-02$38.50/sh−100,000→ 105,583 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2024-06-21+26,014→ 26,014 total
Award
AbCellera Biologics Inc.$ABCL
Share option (right to buy)
2024-06-21+163,934→ 302,490 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2023-06-21+51,501→ 51,501 total
Award
AbCellera Biologics Inc.$ABCL
Share Option (right to buy)
2022-12-01+47,231→ 138,556 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2022-09-15+52,142→ 52,142 total
Award
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2022-09-15+71,850→ 71,850 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2022-06-22+104,921→ 104,921 total
Purchase
BridgeBio Pharma, Inc.$BBIO
Common Stock
2021-12-30$14.30/sh+1,500→ 48,099 total
Purchase
BridgeBio Pharma, Inc.$BBIO
Common Stock
2021-12-29$12.90/sh+6,000→ 46,599 total
Award
AbCellera Biologics Inc.$ABCL
Share Option (right to buy)
2021-12-03+91,325→ 91,325 total
Purchase
AbCellera Biologics Inc.$ABCL
Share Option (right to buy)
2021-12-03$14.02/sh+86,938→ 86,938 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2021-06-17+38,895→ 38,895 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-06-23+101,223→ 101,223 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-19$8.17/sh+4,957→ 22,860,013 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-18$8.21/sh+6,706→ 22,855,056 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-17$8.53/sh+6,541→ 22,848,350 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-14$7.91/sh+7,144→ 22,841,809 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-13$7.95/sh+7,367→ 22,834,665 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-12$8.30/sh+7,500→ 22,827,298 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-11$8.58/sh+7,189→ 22,819,798 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-10$8.35/sh+7,500→ 22,812,609 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-07$7.96/sh+6,649→ 22,805,109 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-06$8.00/sh+7,082→ 22,798,460 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-05$8.02/sh+6,540→ 22,791,378 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-04$7.59/sh+7,500→ 22,784,838 total
Purchase
Myovant Sciences Ltd.
Common Shares, $0.000017727 par value per share
2019-06-04$8.25/sh+2,424,242→ 40,765,599 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-06-03$7.71/sh+5,424→ 22,777,338 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-31$7.70/sh+5,071→ 22,771,914 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-30$7.97/sh+6,951→ 22,766,543 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-30$8.91/sh+300→ 22,766,843 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-29$7.55/sh+6,882→ 22,759,592 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-28$7.68/sh+3,807→ 22,752,710 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-24$7.70/sh+3,796→ 22,748,903 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-23$7.76/sh+4,802→ 22,745,107 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-22$8.06/sh+5,033→ 22,740,305 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-21$8.52/sh+9,995→ 22,735,272 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-20$8.39/sh+1,715→ 22,725,277 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-20$7.98/sh+8,285→ 22,723,562 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-17$7.36/sh+6,200→ 22,715,277 total
Purchase
Urovant Sciences Ltd.
Common Shares, par value $0.000037453 per share
2019-05-16$6.79/sh+5,408→ 22,709,077 total
Purchase
Sio Gene Therapies Inc.
Common Shares, par value $0.00001 per share
2019-03-18$1.50/sh+6,666,667→ 105,952,381 total
Purchase
Sio Gene Therapies Inc.
Common Shares, par value $0.00001 per share
2018-12-18$1.00/sh+10,000,000→ 99,285,714 total

Lo Andrew

Recent Transactions

Companies

Recent Filings

Address